Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 199 75 040.8 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Kombination, umfassend Salmeterol, ggf. in Form eines pharmazeutisch annehmbaren Salzes einschließlich dem Xinafoat, und Fluticasonpropionat |
54 | Title of basic patent | TIGZ | Medikamente enthaltend Salmeterol und Fluticason. |
51 | IPC main class | ICM (ICMV) | A61K 31/57 (2006.01) |
94 | Start of term of protection | LB | Sep 8, 2010 |
94 | End of term of protection | LE | Sep 7, 2013 |
22 | DE application date | DAT | May 17, 1999 |
| Date of publication of application for a certificate | OT | Jul 29, 1999 |
| Date of publication of grant of certificate | PET | Jul 13, 2006 |
71/73 | Applicant/owner | INH | Glaxo Group Ltd., Berkeley Avenue, Glaxo Wellcome House, UB6 ONN Greenford, Middlesex, GB |
74 | Representative | VTR | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 690 05 951.5 |
68 | EP file number of basic patent | GEAKZ | 90 30 9846.5 |
43 | Date of first publication | EVT | Jul 29, 1999 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 44915.00.00 1999-02-24
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 44915.01.00 1999-02-24
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 44915.02.00 1999-02-24
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 44918.00.00 1999-02-24
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 44918.01.00 1999-02-24
|
92 92 92
| Domestic authorisation | GIS GIN GIT
| Bundesinstitut für Arzneimittel und Medizinprodukte 44918.02.00 1999-02-24
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Läkemedelsverket Medical Products Agency Schweden 14591 1998-09-07
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Läkemedelsverket Medical Products Agency Schweden 14592 1998-09-07
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Läkemedelsverket Medical Products Agency Schweden 14593 1998-09-07
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Läkemedelsverket Medical Products Agency Schweden 14594 1998-09-07
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Läkemedelsverket Medical Products Agency Schweden 14595 1998-09-07
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Läkemedelsverket Medical Products Agency Schweden 14596 1998-09-07
|
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 30, 2022 (Show all update days)(Hide all update days)- Apr 30, 2022; Jul 16, 2019; Aug 9, 2017; Jul 11, 2015; May 16, 2015; Feb 27, 2014; Oct 17, 2013; Aug 23, 2013; Aug 1, 2013; Jul 2, 2013; Jun 29, 2013; Jun 13, 2013; Jun 12, 2013; Jun 6, 2013; Apr 30, 2013; Apr 23, 2013; Apr 19, 2013; Apr 18, 2013; Mar 16, 2013; Feb 10, 2013; Oct 18, 2012; Sep 29, 2012; Sep 26, 2012; Aug 14, 2012; Jul 26, 2012; Jun 2, 2012; Jun 1, 2012; Feb 25, 2012; Nov 18, 2011; Nov 1, 2011; Sep 13, 2011; 31.05.2011; May 31, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|